Zurueck zur Suche

Reporte zur Charge UT7744JA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

21Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KY 10 FL 3 TX 3 MO 2 WI 1 GA 1 AR 1

VAERS 2621545

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

schwer
Staat
FL
Alter
38,0
Geschlecht
F
Eingang
26.04.2023
Impfdatum
08.11.2022
Beginn
08.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Abdominal pain Dizziness Hypotension Presyncope Troponin increased Vomiting

Symptomtext

Deveoped severe abdominal pain after injection. Went to ER and got dizzy, nearly fainted. Vomiting, hypotension

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
midly elveated troponin
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
wellbutrin
Vorherige Impfungen
-

VAERS 2491790

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

schwer
Staat
WI
Alter
8,0
Geschlecht
F
Eingang
27.10.2022
Impfdatum
27.10.2022
Beginn
01.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Lethargy Loss of consciousness Pallor Syncope

Symptomtext

Patient anxious prior to receiving vaccine. Approximately one minute after injection complete, patient had syncopal episode that lasted less than one minute. Regained consciousness and was placed with legs elevated above heart. Provided and encouraged patient to consume water. Ice pack applied to back of head while patient rested in dads arms. After approximately 5 minutes, patient had pinkness to her cheeks and lips vs the minute following the syncopal episode when her skin tone changed to pale. Encouraged patient to continue consuming fluids and begin slowly moving feet and hands around. After 15 minutes patient appeared more alert, ambulating independently without complaint of dizziness or lightheadedness. Denied nausea, numbness. Patient remained with this writer and her father while continuing to consume water and converse. Mother came into vaccine room and was educated regarding event. Encouraged parents to provide well rounded meal, push fluids and allow patient to rest. Parents and patient acknowledged reasoning and rationale. Patient remained slightly lethargic upon discharge. Was ambulating independently, conversing and oriented. Patients doctor office contacted by this writer and informed of adverse event. No further questions remained from nurse, patient or parents.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Unknown
Vorgeschichte
unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2521725

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

mild
Staat
MO
Alter
11,0
Geschlecht
M
Eingang
30.11.2022
Impfdatum
02.11.2022
Beginn
-
Tage bis Beginn
-
Dosis
7+
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Incorrect dose administered

Symptomtext

On 11/3/2022 Pt received 0.3ml instead of 00.2ml of Covid vaccine. I called mom to inform her. She was thankful for the call stated that patient was fine that he complained of a stomachache but mom did not think related to vaccine. She thought s/s something he ate. No vomiting, no fever, no other symptoms. On 11/4/2022 follow up call mom referred pt was perfectly fine, went to school, slept well, ate well and went to school. she had no concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
-
Vorherige Impfungen
-

VAERS 2512984

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

mild
Staat
TX
Alter
62,0
Geschlecht
F
Eingang
21.11.2022
Impfdatum
06.10.2022
Beginn
13.11.2022
Tage bis Beginn
38,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
COVID-19 Cough Fatigue Headache Influenza virus test negative Oropharyngeal pain Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Somnolence Sputum discoloured Streptococcus test negative

Symptomtext

11/13/2022 in the morning I had a sore throat, congestion, yellow drainage. I felt worse in the evening, no improvement overnight. 11/14 I went to urgent care, there they tested for Strep, Flu, and COVID-19. All negative. Prescribed an antibiotic and decongestant. 11/15 Aches and fatigue began with all the other symptoms. I fell asleep at 04:30 PM. 11/16 took an at home COVID-19 test and was positive. Reached out to my doctor that day. Doctor prescribed antibody treatment and ordered phenotype test. I tested positive on a PCR COVID-19 test. 11/16 took the antibody treatment with bebtelovimab antibodies. Fever spiked at 100. 11/18 I felt much better after. Symptoms tapered off with a slight cough, slight headache, and some fatigue now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
11/14 I went to urgent care, there they tested for Strep, Flu, and COVID-19. All negative. 11/16 took an at home COVID-19 test, positive. 11/16 PCR COVID-19 test, positive.
Aktuelle Erkrankungen
No
Vorgeschichte
Psoriatic Arthritis; Sjogren's; Lupus; Autoimmune Urticaria; Acid Reflux; Bladder Spasms; Migraine; Spondylosis
Andere Medikamente
Prednisone; hydroxychloroquine; DEXILANT; ALLEGRA; SINGULAIR; famotidine; XELJANZ XR; terbutaline sulfate; XANAX, LYRICA, CELEBREX; ENABLEX; ROBAXIN; BOTOX
Allergien
Penicillin; sulfa; quinolone antibiotics; hydrocodone; leflunomide; TEGADERM adhesives; STELARA; COSENTYX
Vorherige Impfungen
Pneumococcal vaccine MFG Prevnar; 2017; whole arm was red and swollen, lasting about 2 weeks, 57.

VAERS 2506465

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UT7744JA

mild
Staat
GA
Alter
5,0
Geschlecht
M
Eingang
12.11.2022
Impfdatum
20.10.2022
Beginn
20.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Off label use Pain in extremity Product use issue

Symptomtext

arm sore; they gave an expired shot to someone last week; fluzone/20Oct2022; fluzone/20Oct2022; This is a spontaneous report received from contactable reporter(s) (Pharmacist). A 5-year-old male patient received BNT162B2, on 20Oct2022 at 17:41 as dose 1, single (Lot number: FL2757, Expiration Date: 11Oct2022) at the age of 5 years intramuscular, in left deltoid for covid-19 immunisation; influenza vaccine (FLUZONE [INFLUENZA VACCINE]), on 20Oct2022 as dose number unknown, single (Lot number: UT7744JA) intramuscular, in right deltoid for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 20Oct2022, outcome "unknown" and all described as "fluzone/20Oct2022"; EXPIRED PRODUCT ADMINISTERED (non-serious) with onset 20Oct2022 at 17:41, outcome "unknown", described as "they gave an expired shot to someone last week"; PAIN IN EXTREMITY (non-serious) with onset 21Oct2022, outcome "recovered" (2022), described as "arm sore". Therapeutic measures were not taken as a result of pain in extremity. Additional information: caller stated he is calling about the Pediatric Vaccine, verified Pfizer Pediatric Covid Monovalent Vaccine. Caller states he is calling from (name) because they gave an expired shot to someone last week, later clarified to two patients, and corporate told him he needed to reach out to Pfizer to get the stability information to fill out the VAERS form. Caller states he is wondering if there may be extended stability? The seriousness of event arm sore was reported as non-serious. Follow-up attempts are completed. No further information is expected. Follow-up (09Nov2022): This is a spontaneous follow-up report received from a contactable Pharmacist reported in response to HCP letter sent which included that: Updated information included: Co-suspect, new event and additional information. Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201253323 same reporter/product/AE, different patient; Report 1 of 2;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2482505

UNKNOWN MANUFACTURER · INFLUENZA (SEASONAL) (NO BRAND NAME) · Charge UT7744JA

mild
Staat
FL
Alter
40,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
23.09.2022
Beginn
23.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Axillary pain Burning sensation Herpes zoster Off label use Product use issue

Symptomtext

sharp pains and burning in the right armpit; sharp pains and burning in the right armpit; diagnosed with shingles/ developed a rash; off label use; Product use for unapproved combination; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient. A 40-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 at 08:30 as dose number unknown (booster), single (Lot number: GH9702) at the age of 40 years intramuscular, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA), on 23Sep2022 as dose 1, single (Lot number: UT7744JA), in left arm for immunisation. The patient's relevant medical history included: "Sleep apnea" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (primary immunization series complete; manufacturer unknown), for COVID-19 immunisation. The following information was reported: PRODUCT USE ISSUE (non-serious) with onset 23Sep2022, outcome "unknown", described as "Product use for unapproved combination"; OFF LABEL USE (non-serious) with onset 23Sep2022, outcome "unknown"; HERPES ZOSTER (non-serious) with onset 27Sep2022, outcome "recovering", described as "diagnosed with shingles/ developed a rash"; AXILLARY PAIN (non-serious), BURNING SENSATION (non-serious) all with onset 27Sep2022, outcome "recovering" and all described as "sharp pains and burning in the right armpit". The events "sharp pains and burning in the right armpit" and "diagnosed with shingles/ developed a rash" required physician office visit. Therapeutic measures were taken as a result of axillary pain, burning sensation, herpes zoster. Additional information: Other vaccine received in four weeks was "Dynavax, Inc," (not further specified) on16Sep2022 as dose 1, single (Lot number: 938793) in left arm. Within a few days of receiving the COVID booster in the patient's right arm, she began to experience sharp pains and burning in her right armpit. She developed a rash that would not respond to diphenhydramine hydrochloride (BENADRYL), hydrocortisone, or steroid cream. She went to the doctor and was diagnosed with shingles. Treatment received included valacyclovir (VALTREX) on 04Oct2022 and topical ointment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Sleep apnea
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2475786

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

mild
Staat
MO
Alter
40,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
28.09.2022
Beginn
28.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain Product use complaint

Symptomtext

Difficulty administering injection in left deltoid. Needle encountered probable scar tissue, and plunger stalled. The immunization was completed with difficulty. The patient compains today 10/11/22 of lingering soreness, and has increased since date of injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Past Medical History- Opioid Addiction, Addiction to Methamphetamine IV user, Depression, Full Hysterectomy in 2010 Problem List- Code F31.9 Bipolar Depression, Code 11.20 Opioid dependence on agonist therapy, Code F42.4 Skin-picking disorder, Code F15.10 Methamphetamine abuse (positive lab result on 09/13/22)
Vorgeschichte
Past Medical History- Opioid Addiction, Addiction to Methamphetamine IV user, Depression, Full Hysterectomy in 2010 Problem List- Code F31.9 Bipolar Depression, Code 11.20 Opioid dependence on agonist therapy, Code F42.4 Skin-picking disorder, Code F15.10 Methamphetamine abuse (positive lab result on 09/13/22)
Andere Medikamente
risperiDONE 1 mg tablet orally 2 x/day , Suboxone 8 mg-2 mg film sublingually 2 x/day, Narcan 4 mg/0.1 mL spray as directed intranasally, doxepin 10 mg capsule orally 3 x/day, triamcinolone topical 0.5 % cream applied topically 2 x/day
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2471041

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

mild
Staat
AR
Alter
55,0
Geschlecht
F
Eingang
06.10.2022
Impfdatum
03.10.2022
Beginn
04.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Headache

Symptomtext

headache, weakness, achy joints

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2715400

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
FL
Alter
-
Geschlecht
F
Eingang
18.11.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

administered the fluzone quad (prefilled) that expired in june 2023 with no reported adverse event; Initial information received on 07-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age female patient who administered the INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] that expired in june 2023 with no reported adverse event The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received expired dose of a 0.5 ml of suspect Suspension for injection of INFLUENZA QUADRIVAL A-B VACCINE (prefilled) (strength: standard) (lot UT7744JA, expiry date: 30-Jun-2023) via intramuscular route in the left arm as prophylactic vaccination (expired product administered) (latency: same day). Action taken was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2588611

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
46,0
Geschlecht
M
Eingang
28.02.2023
Impfdatum
02.01.2023
Beginn
02.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Covid booster not viable due to improper storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension, sleep apnea, asthma, diabetes, hyperlipidemia, anxiety, GERD, IBS,
Andere Medikamente
albuterol sulfate PROVENTIL HFA;VENTOLIN HFA 90 mcg/actuation Inhalation Inhale 2 Puffs into the lungs every 4 hours as needed for Wheezing. aspirin aspirin 81 mg Oral Take 1 Tablet by mouth daily. blood sugar diagnostic OneTouch Verio te
Allergien
Penicillins
Vorherige Impfungen
-

VAERS 2588591

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
25,0
Geschlecht
F
Eingang
28.02.2023
Impfdatum
02.01.2023
Beginn
02.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Covid booster not viable due to improper storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
Vitamin D deficiency, anxiety, IBS
Andere Medikamente
albuterol sulfate PROVENTIL HFA;VENTOLIN HFA 90 mcg/actuation bupropion HCl WELLBUTRIN XL 300 mg TAKE ONE TABLET BY MOUTH DAILY escitalopram oxalate LEXAPRO 20 mg TAKE 1 AND 1/2 TABLET BY MOUTH DAILY
Allergien
Amoxicillin, penicillins
Vorherige Impfungen
-

VAERS 2588574

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
46,0
Geschlecht
M
Eingang
28.02.2023
Impfdatum
02.01.2023
Beginn
02.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Medication error. Covid booster not viable due to improper storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
A-fib, sleep apnea, interstitial lung disease, hyperlipidemia, addisons disease, diabetes, vitamin D deficiency, hypothyroidism
Andere Medikamente
atorvastatin calcium LIPITOR 10 mg Oral Take 1 Tablet by mouth daily. azelastine HCl ASTELIN 137 mcg (0.1 %) Each Nare 1 Spray in each nostril 2 times daily. Use in each nostril as directed blood sugar diagnostic OneTouch Verio test strip
Allergien
None
Vorherige Impfungen
-

VAERS 2588514

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
34,0
Geschlecht
F
Eingang
28.02.2023
Impfdatum
02.01.2023
Beginn
02.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product storage error

Symptomtext

Medication error. Covid booster not viable due to improper storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma, vitamin D deficiency, prediabetes, depression, ADHD, psoriasis, anemia
Andere Medikamente
acetaminophen TYLENOL 500 mg Oral Take by mouth every 4 hours as needed for Pain. calcipotriene DOVONOX 0.005 % Apply BID to psoriasis on the skin. clobetasol propionate TEMOVATE 0.05 % Apply BID PRN to psoriasis on the trunk and extre
Allergien
Latex, mushroom
Vorherige Impfungen
-

VAERS 2587796

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
36,0
Geschlecht
F
Eingang
27.02.2023
Impfdatum
06.01.2023
Beginn
06.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Covid vaccine was not viable due to improper temperature storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
Diabetes, vitamin D deficiency
Andere Medikamente
blood sugar diagnostic Blood Sugar Diagnostic E11.9 One Touch Verio test strips. Test two times daily. empagliflozin Jardiance 10 mg Oral Take 1 Tablet by mouth daily. lancets Lancets E11.9 One Touch Delica lancets. Test two times dai
Allergien
None
Vorherige Impfungen
-

VAERS 2587010

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
40,0
Geschlecht
F
Eingang
24.02.2023
Impfdatum
09.01.2023
Beginn
09.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Covid vaccine not viable due to improper temperature storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
Allergies, sleep apnea, hyperlipidemia, anxiety, vitamin d deficiency,
Andere Medikamente
aspirin aspirin 81 mg TAKE ONE TABLET BY MOUTH EVERY 12 HOURS FOR 10 DAYS azelastine HCl ASTELIN 137 mcg (0.1 %) Each Nare 2 Sprays in each nostril 2 times daily. cholecalciferol (vitamin D3) Cholecalciferol (Vitamin D3) 50 mcg (2,000 un
Allergien
Iodine
Vorherige Impfungen
-

VAERS 2585652

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
45,0
Geschlecht
M
Eingang
22.02.2023
Impfdatum
11.01.2023
Beginn
11.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Covid vaccine not viable due to improper temperature storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
hyperlipidemia, hypertension, asthma, hypothyroidism, vitamin D deficiency, depression, GERD
Andere Medikamente
albuterol sulfate PROVENTIL HFA;VENTOLIN HFA 90 mcg/actuation INHALE 2 PUFFS BY MOUTH EVERY 4 HOURS AS NEEDED FOR WHEEZE atorvastatin calcium LIPITOR 10 mg TAKE 1 TABLET BY MOUTH EVERY DAY cholecalciferol (vitamin D3) Cholecalciferol (V
Allergien
Lisinopril
Vorherige Impfungen
-

VAERS 2585515

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
49,0
Geschlecht
M
Eingang
22.02.2023
Impfdatum
16.01.2023
Beginn
16.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Vaccine not viable due to improper storage temperature.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
fatigue, urinary hesitancy
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2584342

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
47,0
Geschlecht
F
Eingang
20.02.2023
Impfdatum
17.01.2023
Beginn
17.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Vaccine not viable due to improper temperature storage,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
identity disorder, bulimia, depression, ptsd, anemia, hypothyroidism
Andere Medikamente
escitalopram oxalate LEXAPRO 20 mg Oral Take 1 Tablet by mouth daily. gabapentin NEURONTIN 400 mg Oral Take 1 Capsule by mouth 4 times daily. levothyroxine sodium SYNTHROID 75 mcg Oral Take 1 Tablet by mouth daily.
Allergien
Buspar
Vorherige Impfungen
-

VAERS 2583376

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
KY
Alter
24,0
Geschlecht
F
Eingang
17.02.2023
Impfdatum
19.01.2023
Beginn
19.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Medication error Product storage error

Symptomtext

Medication error. Vaccine not viable due to improper temperature storage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Medication error
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Anxiety/fatigue
Andere Medikamente
ergocalciferol (vitamin D2) DRISDOL 1,250 mcg (50,000 unit) Oral Take 1 Capsule by mouth once a week. levonorgestrel/ethin.estradiol NORDETTE 0.15-0.03 mg Kurvelo (28) 0.15 mg-0.03 mg tablet TAKE 1 TABLET BY MOUTH ONCE DAILY FOR 28 DAYS
Allergien
Tea tree oil
Vorherige Impfungen
-

VAERS 2566677

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
TX
Alter
2,0
Geschlecht
F
Eingang
24.01.2023
Impfdatum
23.01.2023
Beginn
23.01.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered

Symptomtext

PATIENT RECEIVED REGULAR COVID INSTEAD OF BIVALENT. NO REACTIONS OR SYMPTOMS NOTED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2537307

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7744JA

gering
Staat
TX
Alter
2,0
Geschlecht
M
Eingang
19.12.2022
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

There were no symptoms, patient got a 4th dose of Pfizer Bivalent even though it is not authorized as a booster yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
NONE SINCE THERE WERE NO SYMPTOMS OR REACTIONS.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HYDROCORTISONE CREAM 2.5 %.
Allergien
-
Vorherige Impfungen
-